E. Scott Monrad

3.8k total citations
44 papers, 2.9k citations indexed

About

E. Scott Monrad is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E. Scott Monrad has authored 44 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E. Scott Monrad's work include Cardiovascular Function and Risk Factors (14 papers), Acute Myocardial Infarction Research (13 papers) and Cardiac Valve Diseases and Treatments (8 papers). E. Scott Monrad is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Acute Myocardial Infarction Research (13 papers) and Cardiac Valve Diseases and Treatments (8 papers). E. Scott Monrad collaborates with scholars based in United States, Switzerland and Canada. E. Scott Monrad's co-authors include Otto M. Hess, H P Krayenbuehl, William Grossman, Donald S. Baim, Marko Turina, William J. Corin, Tomoyuki Murakami, G. Mall, Jakob Schneider and Eugene Braunwald and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

E. Scott Monrad

44 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Scott Monrad United States 22 2.4k 834 510 405 287 44 2.9k
Yoshio Yasumura Japan 26 1.7k 0.7× 687 0.8× 521 1.0× 264 0.7× 502 1.7× 162 2.7k
Russell J. Ivanhoe United States 12 2.5k 1.0× 1.4k 1.6× 623 1.2× 248 0.6× 351 1.2× 19 3.3k
Sidney C. Smith United States 7 1.9k 0.8× 842 1.0× 687 1.3× 201 0.5× 213 0.7× 23 2.5k
Heikki Ukkonen Finland 25 1.5k 0.6× 543 0.7× 1.0k 2.0× 357 0.9× 224 0.8× 62 2.6k
Jack L. Martin United States 24 3.1k 1.3× 1.8k 2.1× 765 1.5× 175 0.4× 281 1.0× 66 4.0k
Jay N. Cohn United States 11 4.1k 1.7× 745 0.9× 396 0.8× 284 0.7× 515 1.8× 16 4.8k
James R. Bengtson United States 11 1.6k 0.7× 558 0.7× 734 1.4× 197 0.5× 150 0.5× 14 2.1k
L Seipel Germany 29 2.9k 1.2× 682 0.8× 430 0.8× 201 0.5× 271 0.9× 265 3.6k
Sobel Be United States 29 1.9k 0.8× 476 0.6× 784 1.5× 162 0.4× 302 1.1× 66 3.1k
Jang‐Ho Bae South Korea 21 1.2k 0.5× 894 1.1× 360 0.7× 143 0.4× 273 1.0× 99 2.1k

Countries citing papers authored by E. Scott Monrad

Since Specialization
Citations

This map shows the geographic impact of E. Scott Monrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Scott Monrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Scott Monrad more than expected).

Fields of papers citing papers by E. Scott Monrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Scott Monrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Scott Monrad. The network helps show where E. Scott Monrad may publish in the future.

Co-authorship network of co-authors of E. Scott Monrad

This figure shows the co-authorship network connecting the top 25 collaborators of E. Scott Monrad. A scholar is included among the top collaborators of E. Scott Monrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Scott Monrad. E. Scott Monrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monrad, E. Scott, et al.. (2020). Prevalence and association of the Wellens' sign with coronary artery disease in an ethnically diverse urban population. Journal of Electrocardiology. 62. 211–215. 6 indexed citations
2.
Narasimhan, Seshasayee, et al.. (2012). Severe Multivessel Coronary Vasospasm Presenting as Acute ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 60(15). 1429–1429. 5 indexed citations
3.
Negassa, Abdissa, E. Scott Monrad, & Vankeepuram Srinivas. (2009). A Simple Prognostic Classification Model for Postprocedural Complications After Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the New York State Percutaneous Coronary Intervention Database). The American Journal of Cardiology. 103(7). 937–942. 4 indexed citations
5.
Harris, Tiffany G., Howard D. Strickler, Herbert Yu, et al.. (2006). Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Hormone & IGF Research. 16(2). 86–92. 21 indexed citations
7.
Barnhart, Janice, E. Scott Monrad, & Hillel W. Cohen. (2003). Physicians’ Perceptions of the Effect of Nonclinical Factors on Coronary Revascularization. PubMed. 5(5). 313–319. 8 indexed citations
8.
Rybicki, Anne C., et al.. (2002). Elevated levels of Factor XI are associated with cardiovascular disease in women. Thrombosis Research. 107(1-2). 55–60. 39 indexed citations
9.
Monrad, E. Scott, et al.. (2001). A randomized trial of stenting with or without balloon predilation for the treatment of coronary artery disease. American Heart Journal. 142(5). 10A–13A. 18 indexed citations
10.
Wong, S. Chiu, Lynn A. Sleeper, E. Scott Monrad, et al.. (2001). Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. Journal of the American College of Cardiology. 38(5). 1395–1401. 94 indexed citations
11.
Menon, Venu, John G. Webb, L. David Hillis, et al.. (2000). Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 36(3). 1110–1116. 240 indexed citations
12.
Monrad, E. Scott. (2000). Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non–q-wave acute myocardial infarction. The American Journal of Cardiology. 85(8). 2–9. 5 indexed citations
13.
Adler, David, E. Scott Monrad, Edmund H. Sonnenblick, Otto M. Hess, & Hans P. Krayenbuehl. (1996). Time to dp/dtmax, a useful index for evaluation of contractility in the catheterization laboratory. Clinical Cardiology. 19(5). 397–403. 10 indexed citations
14.
Jondeau, Guillaume, Stuart D. Katz, Jean‐François Toussaint, et al.. (1993). Regional specificity of peak hyperemic responses in patients with congestive heart failure: Correlation with peak aerobic capacity. Journal of the American College of Cardiology. 22(5). 1399–1402. 54 indexed citations
15.
Corin, William J., et al.. (1991). Flosequinan: A vasodilator with positive inotropic activity. American Heart Journal. 121(2). 537–540. 23 indexed citations
16.
17.
Hess, Otto M., et al.. (1988). Left ventricular volume determination in dogs: a comparison between conductance technique and angiocardiography. European Heart Journal. 9(9). 1018–1026. 11 indexed citations
18.
Krayenbuehl, H P, et al.. (1988). Left ventricular systolic function in aortic stenosis. European Heart Journal. 9(suppl E). 19–23. 52 indexed citations
19.
Monrad, E. Scott, et al.. (1986). Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.. PubMed. 73(3 Pt 2). III205–12. 19 indexed citations
20.
Baim, Donald S., Wilson S. Colucci, E. Scott Monrad, et al.. (1986). Survival of patients with severe congestive heart failure treated with oral milrinone. Journal of the American College of Cardiology. 7(3). 661–670. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026